KR20030066797A - 흥분성 아미노산 수용체 길항제 - Google Patents

흥분성 아미노산 수용체 길항제 Download PDF

Info

Publication number
KR20030066797A
KR20030066797A KR10-2003-7008977A KR20037008977A KR20030066797A KR 20030066797 A KR20030066797 A KR 20030066797A KR 20037008977 A KR20037008977 A KR 20037008977A KR 20030066797 A KR20030066797 A KR 20030066797A
Authority
KR
South Korea
Prior art keywords
compound
pharmaceutically acceptable
formula
alkyl
acceptable salt
Prior art date
Application number
KR10-2003-7008977A
Other languages
English (en)
Korean (ko)
Inventor
비엔 반 카우
마이클 에드워드 레투어노
마이클 존 마르티넬리
Original Assignee
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 일라이 릴리 앤드 캄파니 filed Critical 일라이 릴리 앤드 캄파니
Publication of KR20030066797A publication Critical patent/KR20030066797A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR10-2003-7008977A 2001-01-05 2001-12-20 흥분성 아미노산 수용체 길항제 KR20030066797A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26001401P 2001-01-05 2001-01-05
US60/260,014 2001-01-05
PCT/US2001/044715 WO2002053561A1 (en) 2001-01-05 2001-12-20 Excitatory amino acid receptor antagonists

Publications (1)

Publication Number Publication Date
KR20030066797A true KR20030066797A (ko) 2003-08-09

Family

ID=22987455

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-7008977A KR20030066797A (ko) 2001-01-05 2001-12-20 흥분성 아미노산 수용체 길항제

Country Status (23)

Country Link
EP (1) EP1351955A1 (zh)
JP (1) JP2004520335A (zh)
KR (1) KR20030066797A (zh)
CN (1) CN1484642A (zh)
AR (1) AR035679A1 (zh)
BR (1) BR0116672A (zh)
CA (1) CA2431545A1 (zh)
CZ (1) CZ20031856A3 (zh)
DZ (1) DZ3460A1 (zh)
EA (1) EA200300770A1 (zh)
EC (1) ECSP034682A (zh)
HR (1) HRP20030544A2 (zh)
HU (1) HUP0302528A2 (zh)
IL (1) IL156138A0 (zh)
MX (1) MXPA03005981A (zh)
NO (1) NO20032973L (zh)
NZ (1) NZ525821A (zh)
PE (1) PE20020792A1 (zh)
PL (1) PL361934A1 (zh)
SK (1) SK8242003A3 (zh)
TW (1) TW591023B (zh)
WO (1) WO2002053561A1 (zh)
ZA (1) ZA200304311B (zh)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
IL137684A0 (en) * 1998-02-06 2001-10-31 Smithkline Beechmam Plc Salts of paroxetine
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
DK1200073T3 (da) * 1999-07-06 2007-05-07 Lilly Co Eli Selektive iGluR5-receptorantagonister til behandling af migræne

Also Published As

Publication number Publication date
SK8242003A3 (en) 2004-01-08
PE20020792A1 (es) 2002-09-06
CN1484642A (zh) 2004-03-24
TW591023B (en) 2004-06-11
ZA200304311B (en) 2004-09-02
JP2004520335A (ja) 2004-07-08
IL156138A0 (en) 2003-12-23
ECSP034682A (es) 2003-08-29
NO20032973D0 (no) 2003-06-27
NO20032973L (no) 2003-06-27
NZ525821A (en) 2004-07-30
AR035679A1 (es) 2004-06-23
PL361934A1 (en) 2004-10-18
HRP20030544A2 (en) 2004-08-31
BR0116672A (pt) 2003-09-23
MXPA03005981A (es) 2003-09-10
HUP0302528A2 (hu) 2003-11-28
DZ3460A1 (fr) 2002-07-11
CA2431545A1 (en) 2002-07-11
EA200300770A1 (ru) 2003-10-30
CZ20031856A3 (cs) 2003-09-17
WO2002053561A1 (en) 2002-07-11
EP1351955A1 (en) 2003-10-15

Similar Documents

Publication Publication Date Title
JP4619595B2 (ja) 偏頭痛の処置のための選択的なｉＧｌｕＲ５受容体拮抗薬
US6579886B2 (en) Selective iglur5 receptor antagonists
JP4132049B2 (ja) 興奮性アミノ酸レセプターアンタゴニスト
US6855725B2 (en) Excitatory amino acid receptor antagonists
KR20030066797A (ko) 흥분성 아미노산 수용체 길항제
US6953805B2 (en) Excitatory amino acid receptor antagonists
US20040082606A1 (en) Excitatory amino acid receptor antagonists
US6924294B2 (en) Excitatory amino acid receptor antagonists
AU2002227021A1 (en) Excitatory amino acid receptor antagonists
JP2004522804A5 (zh)
EP1351689A2 (en) Derivatives of the (3s, 4ar, 6s, 8ar) 6-phenylamino-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid as excitatory amino acid receptor antagonists for the treatment of neurological disorders and neurodegenerative diseases
US7205313B2 (en) Excitatory amino acid receptor antagonists
JP2004520335A5 (zh)

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid